DTI-ALPS biomarker ties glymphatic dysfunction to cognitive decline, offering new insights into vascular dementia treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback